


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+10.44%
-1.16%
-4.82%
+0.92%
+0.72%
LMAT
LeMaitre Vascular In
$84.67
Strengths

Upgraded on attractively valued
Chart
$89.54 (-5.44%)
$95.03 (-10.90%)
$84.39 (+0.33%)
$101.14 (-16.28%)
LMAT has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Low volume

LMAT overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future
![]()
LMAT Analysts opinion is negative but has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
LMAT Street Sentiment is bullish and have negative views on the near-term outlook
Average key support and resistance price levels.
Login to displayWhat is LMAT current stock price?
What are LMAT stock strengths?
What is LMAT Risk Level?
What is LMAT market cap and volume?
What is LMAT current Stock IQ?
Should I buy LMAT stock right now?
Is LMAT a Strong Buy right now?
What does a 'Strong Buy' rating mean for LMAT?
What does a 'Strong Sell' rating mean for LMAT?
What factors influence LMAT's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+10.44%
-1.16%
-4.82%
+0.92%
+0.72%
LMAT
LeMaitre Vascular In
Current Price
$84.67
Stock Insights
Strengths

Upgraded on attractively valued

Chart
$89.54 (-5.44%)
$95.03 (-10.90%)
$84.39 (+0.33%)
$101.14 (-16.28%)
LMAT Analysts Opinion
LMAT Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future
![]()
LMAT Analysts opinion is negative but has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
LMAT Street Sentiment is bullish and have negative views on the near-term outlook
LMAT has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Low volume

Average key support and resistance price levels.
LMAT Latest Analysis
Ex-Dividend Reminder: CenterPoint Energy Regeneron Pharmaceuticals and LeMaitre Vascular . Looking at the universe of stocks we cover at Dividend Channel on 11/20/25 CenterPoint Energy Inc (Symbol: CNP) Regeneron Pharmaceuticals Inc. (Symbol: REGN) and LeMaitre Vascular Inc (Symbol: LMAT) will all trade ex-dividend for their respective upcoming dividends. Center
Tue Nov 18, 2025
LeMaitre Vascular (LMAT) Q3 Earnings Surpass Estimates. LeMaitre (LMAT) delivered earnings and revenue surprises of 8.77% and -2.03% respectively for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Fri Nov 7, 2025
LeMaitre Vascular declares $0.20 dividend.
Fri Nov 7, 2025
LeMaitre Vascular Non-GAAP EPS of $0.62 beats by $0.06 revenue of $61M misses by $1.17M.
Thu Nov 6, 2025
LeMaitre Vascular Inc. Q3 Profit Increases Beats Estimates . (RTTNews) - LeMaitre Vascular Inc. (LMAT) announced earnings for its third quarter that Increased from last year and beat the Street estimates.
Thu Nov 6, 2025
Roth Capital Reiterates LeMaitre Vascular (LMAT) Buy Recommendation. Fintel reports that on November 5 2025 Roth Capital reiterated coverage of LeMaitre Vascular (NasdaqGM:LMAT) with a Buy recommendation. Analyst Price Forecast Suggests 23.72% Upside
Thu Nov 6, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
LMAT Stock trends
LMAT Stock performance
LMAT Stock analysis
LMAT investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.